Stephan Alexander Hüsler

Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals.

ImVision Therapeutics, Inc. develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. The company was founded on January 28, 2005 and is headquartered in Hanover, Germany.

Medimaps Group SA designs and provides medical tools. The company is headquartered in Plan-les-Ouates, Switzerland.

Fisch Asset Management AG (Fisch) is an independent Swiss asset management firm which was founded by Kurt Fisch and Pius Fisch in 1994. Based in Zurich, the firm manages a range of convertible bond, corporate bond, multi-asset and managed futures strategies primarily for institutional clients such as banks, portfolio managers, pension funds and family offices, as well as for wholesale investors. They are a signatory to the UN Principles for Responsible Investment and integrate socially responsible factors into their investment processes.